Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.

Lu DH, Yang J, Gao LK, Min J, Tang JM, Hu M, Li Y, Li ST, Chen J, Hong L

Open source

DOI
10.3892/or.2018.6888
Published
2019 Feb
Container
Oncology reports
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 27/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/or.2018.6888,
  title = {Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.},
  author = {Lu DH and Yang J and Gao LK and Min J and Tang JM and Hu M and Li Y and Li ST and Chen J and Hong L},
  year = {2019},
  journal = {Oncology reports},
  doi = {10.3892/or.2018.6888},
  url = {https://doi.org/10.3892/or.2018.6888}
}

RIS

TY  - JOUR
TI  - Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
AU  - Lu DH
AU  - Yang J
AU  - Gao LK
AU  - Min J
AU  - Tang JM
AU  - Hu M
AU  - Li Y
AU  - Li ST
AU  - Chen J
AU  - Hong L
PY  - 2019
JO  - Oncology reports
DO  - 10.3892/or.2018.6888
UR  - https://doi.org/10.3892/or.2018.6888
ER  - 

APA

DH, L., J, Y., LK, G., J, M., JM, T., M, H., Y, L., ST, L., J, C., & L, H. (2019). Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.. Oncology reports. https://doi.org/10.3892/or.2018.6888

Source records